Sign In
Buy GLYC
$15.71
+0 (+0%)
At Close: Oct 01, 2025
Acura Pharmaceuticals (OTCMKTS:ACUR) and GlycoMimetics (OTCMKTS:GLYC) Head-To-Head Contrast
02:38am, Sunday, 02'nd Aug 2020
Acura Pharmaceuticals (OTCMKTS:ACUR) and GlycoMimetics (NASDAQ:GLYC) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength o
GlycoMimetics Inc (GLYC) Q2 2020 Earnings Call Transcript
10:30pm, Friday, 31'st Jul 2020
Good morning, and thank you all for joining GlycoMimetics Corporate Update Conference Call. The webcast replay will also be available in the Investor Relations section of the Company's website for 30
GlycoMimetics, Inc. (GLYC) CEO Rachel King on Q2 2020 Results - Earnings Call Transcript
08:33pm, Friday, 31'st Jul 2020
GlycoMimetics, Inc. (NASDAQ:GLYC) Q2 2020 Earnings Conference Call July 31, 2020 08:30 AM ET Company Participants Shari Annes - Investor Relations Rachel King - Chief Executive Officer Brian Hahn - Se
GlycoMimetics Reports Highlights and Financial Results for Second Quarter 2020
12:00pm, Friday, 31'st Jul 2020
GlycoMimetics, Inc. (Nasdaq: GLYC) today reported its financial results for the second quarter ended June 30, 2020, and highlighted recent company events. Cash and cash equivalents at June 30, 2020 we
Earnings Scheduled For July 31, 2020
12:00am, Friday, 31'st Jul 2020
Companies Reporting Before The Bell
• Chevron Inc. (NYSE:CVX) is expected to report quarterly loss at $0.92 per share on revenue of $22.10 billion.
• Weyerhaeuser Inc. (...
GlycoMimetics to Report Second Quarter Financial Results on July 31, 2020
01:15pm, Friday, 24'th Jul 2020
GlycoMimetics, Inc. (Nasdaq: GLYC) announced today that it will host a conference call and webcast to report its second quarter financial results on Friday, July 31, 2020, at 8:30 a.m. ET.
Here's Why We're Not Too Worried About GlycoMimetics' (NASDAQ:GLYC) Cash Burn Situation
02:45pm, Wednesday, 22'nd Jul 2020
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...
Diversified Trust Co Buys New Stake in GlycoMimetics Inc (NASDAQ:GLYC)
04:04am, Sunday, 12'th Jul 2020
Diversified Trust Co purchased a new stake in GlycoMimetics Inc (NASDAQ:GLYC) in the 2nd quarter, according to its most recent filing with the SEC. The fund purchased 15,522 shares of the biotechnolog
GlycoMimetics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
01:00pm, Friday, 10'th Jul 2020
GlycoMimetics, Inc. (the "Company") (NASDAQ:GLYC) today announced that the compensation committee of the Company’s Board of Directors approved the grant on July 6, 2020 of a non-qualified stock opti
Major Asset Classes: June 2020 Performance Review
11:21am, Thursday, 02'nd Jul 2020
The MSCI Emerging Markets Index jumped 7.4%, marking the third straight monthly gain. The Russell 3000 Index posted a 2.3% gain - the third consecutive monthly
Risk Premia Forecasts For Major Asset Tick Higher, Again
12:00am, Thursday, 02'nd Jul 2020
Stocks Analysis by James Picerno covering: iShares Russell 3000 ETF. Read James Picerno's latest article on Investing.com
Emerging Markets Outperform Other Major Asset Classes In June
12:00am, Wednesday, 01'st Jul 2020
Market Overview Analysis by James Picerno covering: Vanguard Russell 3000 Index Fund ETF Shares, MSCI Emerging Markets. Read James Picerno's latest article on Investing.com
Were Hedge Funds Right About Piling Into GlycoMimetics, Inc. (GLYC)?
10:30pm, Tuesday, 30'th Jun 2020
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail invest
GlycoMimetics (GLYC) in Focus: Stock Moves 8.1% Higher
12:48pm, Tuesday, 30'th Jun 2020
GlycoMimetics (GLYC) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.
Two Sigma Investments LP Acquires 74,905 Shares of GlycoMimetics Inc (NASDAQ:GLYC)
10:09am, Friday, 26'th Jun 2020
Two Sigma Investments LP lifted its holdings in GlycoMimetics Inc (NASDAQ:GLYC) by 37.3% in the first quarter, according to the company in its most recent filing with the SEC. The fund owned 275,725 s
